[page 56↓]

References

1. Metzger BE, Coustan DR. Summary and Recommendations of the 4th International Workshop-Conference on Gestational Diabetes. Diabetes Care 1998; 21 (Suppl.): 161-167.

2. Coustan DR, Nelson C, Carpenter MW, Carr SR, Rotondo L, Widness JA. Maternal age and screening for gestational diabetes. A population based study . Obstet Gynecol 1989 ; 73 : 557-561 .

3. Naylor C, Sermer M, Chen E. Selective screning for gestational diabetes mellitus. N Engl J Med 1997; 337: 1591-6.

4. Harris S, Caulfield L, Sugamori M, Whalen E, Henning B. The epidemiology of diabetes in pregnant native Canadians. JAMA 1997; 20: 1422-5.

5. Friedman J, Ishizuka T, Shao J. Impaired glucose transport and insulin receptor tyrosine phosporylation in skeletal muscle from obese women with gestational diabetes. Diabetes 1999; 48: 1807-14.

6. Ryan E, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988; 67: 341-7.

7. Kühl C. Etiology and pathogenesis of gestational diabetes. Diabetes Care 1998; 21: B19-26.

8. Buchanan, T. Pancreatic ß-cell defects in gestational diabetes: implications for the pathophysiology and prevention of type 2 diabetes. J Clinical Endocrinol Metab 2001; 86: 989-93.

9. Schaefer-Graf U, Buchanan T, Xiang A, Peters R, Kjos S. Clinical predictors for a high risk for development of diabetes mellitus in the early puerperium in women with recent gestational diabetes. Am J Obstet Gynecol 2002; 186: 751-6.

10. Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk associated with abnormal glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 1991; 165: 914-919.

11. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Diabetes 1995; 44: 586-591.

12. Buchanan T, Xiang A, Kjos S, Lee W, Trigo E, Nader I, et al. Gestational diabetes: Antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998; 47: 1302-1310.

13. Persson B, Hanson U, Hartling S. Follow-up of women with previous GDM: insulin, C-peptide, and proinsulin response to oral glucose load. Diabetes 1991; 40: 136-41.


[page 57↓]

14. Pedersen J, Osler M. Hyperglycemia as the cause of characteristic features of the foetus and newborn in diabetic mothers. Dan Med Bull 1961; 8: 78.

15. Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol 1998,179: 476-80.

16. Pettitt D, Bennett P, Knowler W, Carraher M, Bennett P, Knowler W. Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes 1988; 37: 622-8.

17. Vohr B, McGarvey S. Effect of maternal gestational diabetes on offspring adiposity at 4-7 years of age. Diabetes Care 1999; 22: 1284-91.

18. Plagemann A, Harder T, Kohlhoff R, Rhode W, Dörner G. Glucose tolerance and insulin secretion in children of mothers with pregestational or gestational diabetes. Diabetologia 1997; 40: 1094-100.

19. Arbeitsgemeinschaft Diabetes und Schwangerschaft der Deutsche Diabetes Gesellschaft. Empfehlungen zu Diagnostik und Therapie des Gestationsdiabetes. FRAUENARZT 2001; 42: 891-899.

20. Carpenter M, Coustan D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-773.

21. O'Sullivan J, Mahan C. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964; 13: 278-285.

22. Bung P, Artal R, Khodiguian N, Kjos S. Exercise in gestational diabetes. An optional therapeutic approach? Diabetes 1991 ; 40 ( Suppl.2) : 182-5 .

23. Molsted-Pedersen L, Tygstrup I, Pederson J. Congenital malformations in newborn infants of diabetic women. Lancet 1964; 1: 1124-1126.

24. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983; 6(3): 219-23.

25. Reiher H, Fuhrmann K, Jutzi E, Hahn HJ. Fetal hyperinsulinism in early pregnancy--a cause of diabetic fetopathy? Zentralbl Gynakol 1983; 105(14): 889-93.

26. Simpson J, Elias S, Martin A, Palmer M, Ogata E, Radvany R. Prospective study of anomalies in offspring of mothers with diabetes mellitus. Am J Obstet Gynecol 1983; 146: 263-270.

27. Kitzmiller J, Gavin L, Gin G, Jovanonvic-Peterson L, Main E, Zigrang W. Preconception care of diabetes: glycemic control prevents congenital anomalies. JAMA 1991; 265: 731-736.


[page 58↓]

28. Martinez-Frias M. Epidemiological analysis of outcomes of pregnany in diabetic mothers. Am J Med Genet 1994; 51: 108-113.

29. Miller E, Hare J, Clohery J. Elevated maternal hemoglobin A1 in early pregnancy and major congenital anomalies in infants of diabetic mothers. N Engl J Med 1981; 304: 1331-1334.

30. Hanson U, Persson B, Thunell S. Relationship between hemoglobin A1c in early type I (insulin- dependent) diabetic pregnancy and the occurrence of spontaneous abortion and fetal malformation in Sweden. Diabetologia 1990; 33: 100-104.

31. Rosenn B, Miodovnik M, Combs C, Khoury J, Siddiqi T. Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus. Obstet Gynecol 1994; 84: 515-520.

32. Fuhrmann K, Reiher H, Semmler K, Glockner E. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol 1984; 83: 173-177.

33. Eriksson U, Dahlstrom E, Larsson K, Hellerstrom C. Increased incidence of congenital malformations in the offspring of diabetic rats and their prevention by maternal insulin therapy. Diabetes 1982; 30: 1-6.

34. Harris M. Epidemiological correlates of NIDDM in Hispanics, Whites, and Blacks in the U.S. population. Diabetes Care 1991; 14 (Suppl.3): 639-648.

35. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979; 29: 1039-1057.

36. American Diabetes Association. Clinical practice recommendations 1996: screening for diabetes. Diabetes Care 1996; 19 (Suppl.9: 5-6.

37. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1998; 21: S5-S19.

38. Sermer M, Naylor DC, for the investigators of the Toronto Tri-Hospital Study . Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without diabetes. Am J Obstet Gynecol 1995; 173: 146-56.

39. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R. Relation of glucose tolerance to complications of pregnancy in non diabetic women. N Engl J Med 1986; 315: 989-92.

40. Berkus MD, Langer O. Glucose tolerance test: Degree of glucose abnormality correlates with neonatal outcome. Obstet Gynecol 1993; 81: 344-8.


[page 59↓]

41. Langer O, Brustman L, Anyaegbunam A. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 1987; 157: 758-63.

42. Mestman JH. Outcome of diabetes screening in pregnancy and perinatal morbidity in infants of mothers with mild impairment in glucose tolerance. Diabetes Care 1980; 3: 447-52.

43. Jovanovic-Peterson L, Peterson CM, Reed GF, Metzger BE, Mills JL, Knopp R, et al. Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study. Am J Obstet Gynecol 1991; 164: 103-111.

44. Susa JB, Schwartz R. Effects of hyperinsulinemia in the primate fetus. Diabetes 1985; 34 (Suppl.2): 36-41.

45. Combs C, Gunderson E, Kitzmiller J, Gavin L, Main E. Relationship of fetal macrosomia to maternal glucose control during pregnancy. Diabetes Care 1992; 15: 1251-1257.

46. Reiher H, Fuhrmann K, Noack S, Woltanski KP, Jutzi E, Hahn von Dorsche H, et al. Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 1983; 6(5): 446-51.

47. Ogata E, Sabbagha R, Metzger B, Phelps R, Depp R, Freinkel N. Serial ultrasonography to assess evolving fetal macrosomia. JAMA 1980; 243: 2405-2408.

48. Hadlock FP, Deter RL, Harrist RB, Park SK. Estimated fetal age: Computer-assisted analysis of multiple fetal growth parameters. Radiology 1984; 152: 497-501.

49. Andres R, Elahi D, Tobin J, Muller B, Brant L. Impact of age on weight goals. In: National Institut of Health Consensus Development Conference. Health implications of obesity. Ann Int Med 1985; 102: 1030-33.

50. Kalkhoff RK. Impact of maternal fuels and nutritional state on fetal growth. Diabetes 1991; 40 (Suppl. 2): 61-66.

51. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening: importance of plasma triglyceride. Diabetes Care 1992; 15: 1605-1613.

52. Hollingsworth D, Ney D, Stubblefield N, Fell T. Metabolic and therapeutic assessment of gestational diabetes by two-hour and twenty-four isocaloric meal tolerance tests. Diabetes 1985; 34: 81-87.

53. Langer O. Fetal macrosomia. Clin Obstet Gynecol 2000; 43: 283-287.


[page 60↓]

54. Keller J, Metzger B, Dooley S, Tamura R, Sabbagha R, Freinkel N. Infants of diabetic mothers with accelerated fetal growth by ultrasonography. Am J Obstet Gynecol 1990; 163: 893-7.

55. Landon MB, Mintz MC, Gabbe SG. Sonographic evaluation of fetal abdominal growth: Predictor of large-for-gestational-age infant in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1989; 160: 115-121.

56. Bochner CJ, Medearis AL, Williams J, Castro L, Hobel CJ, Wade ME. Early third-trimester ultrasound screening in gestational diabetes to determine the risk of macrosomia and labor dystocia at term. Am J Obstet Gynecol 1987; 157: 703-708.

57. Coustan DR, Imarah J. Prophylactic insulin therapy treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery and birth trauma. Am J Obstet Gynecol 1984; 150: 836-842.

58. Jovanovic-Peterson L, Bevier W, Peterson C. The Santa Barbara County Health Services Program: birth weight change concomitant with screening for and treatment of glucose-intolerance of pregnancy: a potential cost-effective intervention ? Am J Perinatol 1997; 14: 221-8.

59. Langer O, Levy J, Brustmann L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus- How tight is enough: Small for gestational age versus large for gestational age. Am J Obstet Gynecol 1989; 161: 646-53.

60. Buchanan TA, Kjos SL, Montoro MN, Wu P, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care 1994; 17: 275-283.

61. Buchanan TA, Kjos SL, Schaefer UM, Peters R, Xiang A, Byrne J et al. Utility of fetal measurements in the management of gestational diabetes. Diabetes Care 1998; 21 (Suppl.2): 99-106.

62. Kjos S, Schaefer-Graf U, Sardesi S, Peters R, Buley A, Xiang A et al. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care 2001; 24: 1904-1910.

63. Catalano P, Thomas A, Huston L, Fung C. Effect of maternal metabolism on fetal growth and body composition. Diabetes Care 1998; 21: 85-90.

64. Kehl R, Krew M, Thomas A, Catalano P. Fetal growth and body composition in infants of women with diabetes mellitus during pregnancy. Matern Fetal Med 1996; 5: 273-80 .


[page 61↓]

65. Weiss P, Hofmann H. Diagnosis and treatment of gestational diabetes according to amniotic fluid insulin levels. Arch Gynecol 1986; 239: 81-91.

66. Weiss PAM. Gestational diabetes: A survey and the Graz approach to diagnosis and therapy. In: Weiss P, Coustan D, eds. Gestational Diabetes. Wien: Springer-Verlag; 1988: 1-55.

67. Weiss P, Hofmann H, Kainer F. Fetal outcome in gestational diabetes with elevated amniotic fluid insulin levels. Diabetes Res Clin Pract 1988; 5(1): 1-7.

68. Weiss PAM, Hofmann HMH. Monitoring pregnancy in diabetes: Amniotic fluid. Diab. Nutr. Metab. 1990; 3(Suppl.2): 31-35.

69. Woltmann W, Dudenhausen JW. Insulin, C-Peptide und IGF 1 im Fruchtwasser stoffwechselgesunder Schwangeren ( Insulin, c-peptide and IGF 1 in amniotic fluid of metabolic healthy women) [Dissertation]. Freie Universitaet Berlin; 1994.

70. Kainer F, Weiss PAM, Hüttner U, Haas J. Ultrasound growth parameters in relation to levels of amniotic fluid insulin in women with diabetes type I. Early Hum Dev 1997; 49: 113-121.

71. Burkhart W, Holzgreve W, Dame WR, Schneider HPG. Antenatal assessment of fetal outcome in pregnant diabetics. J Perinat Med 1986; 14: 293-297.

72. Metzger BE, Freinkel N. Amniotic fluid insulin as a predictor of obesity. Arch Dis Child 1990, 65: 1050-2.

73. Schaefer-Graf UM, Dupak J, Vogel M, Dudenhausen JW, Kjos SL, Buchanan TA, et al. Hyperinsulinism, neonatal adiposity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. J Perinatal Med. 1998; 26: 27-36.

74. Sermer M, Naylor CD, Farine D, Kenshold AB, Ritchie JWK, Gare DJ, et al. The Toronto Tri-Hospital Gestational Diabetes Project. A preliminary review. Diabetes Care 1998; 21 (Suppl. 2): B33-B42.

75. Langer O, Anyuaegbunam A, Brustman L, Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 1989; 161: 593-9.

76. Innes K, Wimsatt J, McDuffie R. Relative glucose tolerance and subsequent development of hypertension in pregnancy. Obstet Gynecol 2001; 97: 905-10.


[page 62↓]

77. Parretti E, Mecacci F, Papini M, Cioni R, Carignani L, Mignosa M, et al. Third-trimester maternal glucose levels from diurnal profiles in nondiabetic pregnancies: correlation with sonographic parameters of fetal growth. Diabetes Care 2001; 24: 1317-8.

78. Burke B, Sherift R. Diabetic twins: an unequal result. Lancet 1979: 1372-73.

79. American College of Obstetricians and Gynecologists. Practice Bulletin: Gestational Diabetes. Obstet Gynecol 2001; 98: 525-538.

80. Jensen D, Damm P, Soresen B, Molsted-Pedersen L, Westergaard J, Klebe J, et al. Clinical impact of mild carbohydrate intolerance in pregnancy: A study of 2904 nondiabetic Danish women with risk factors for gestational diabetes mellitus. Am J Obstet Gynecol 2001; 185: 413-9.

81. Raychaudhuri K, Maresh J. Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol 2000; 95: 190-194.

82. Langer O, Mazze R. The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes. Am J Obstet Gynecol 1988; 159: 1478-83.

83. Langer O. A spectrum of glucose thresholds may effectively prevent complications in pregnant diabetic patients. Semin Perinatol 2002; 26: 196-205.

84. Buchanan T, Kjos S. Gestational diabetes: risk or myth? J Clin Endorinol Metab 1999; 84: 1854-1857.

85. American Diabetes Association. Gestational Diabetes. Diabetes Care 1999; 22 (Suppl. 1): S74-S76.

86. Metzger BE. Summery and recommendations of the 3rd international workshop-conference on gestational diabetes. Diabetes 1991; 40 (Suppl 2): 197-201.

87. Arbeitsgemeinschaft Diabetes und Schwangerschaft der Deutsche Diabetes Gesellschaft. Diagnostik und Therapie des Gestationsdiabetes. Richtlinien der Deutschen Diabetes-Gesellschaft. Der Frauenarzt 1993 ; 34: 13-14.

88. De Veciana M, Major C, Morgan M, Asrat T, Toohey J, Lien J, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. NEJM 1995; 333: 1237-41.

89. Schaefer-Graf U, Kjos S, Kilavuz Ö, Plagemann A, Brauer M, Dudenhausen J, et al. Determinants of fetal growth different periods of pregnancies complicated by Gestational Diabetes or impaired glucose tolerance. Diabetes Care 2003; 26: 193-198.

90. Hadden D. When and how to start insulin treatment in gestational diabetes: A UK perspective. Diabet Med 2001; 18: 960-964.


[page 63↓]

91. Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care 1998; 21(Suppl.2): B79-84.

92. Leikin EL, Jenkins JH, Pomerantz G, Klein L. Abnormal glucose screening test in pregnancy: A risk factor for fetal macrosomia. Obstet Gynecol 1987; 69: 570-73.

93. Jang H, Cho N, Min Y, Han I, Jung K, Metzger B. Increased macrosomia and perinatal morbidity independent of maternal obesity and advanced age in Korean women with GDM. Diabetes Care 1997; 20: 1582-1582.

94. Evers I, De Valk H, Mol B, Ter Braak E, Viser G. Macrosomia despite good glycemic control in type I diabetic pregnancy; result of a nationwide study in the Netherlands. Diabetologia 2002; 45: 1484-1489.

95. Becerra J, Khoury M, Cordero J, Erickson J. Diabetes mellitus in pregnancy and risk of specific birth defects: a population- based case control study. Pediatrics 1990; 85: 1-9.

96. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, et al. Congenital malformations in pregnancies complicated by NIDDM. Diabetes Care 1995; 18: 1446-1451.

97. Schaefer UM, Songster G, Xiang A, Berkowitz K, Buchanan TA, Kjos SL. Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy. Am J Obstet Gynecol 1997; 177: 1165-1171.

98. Schaefer-Graf U, Buchanan T, Xiang A, Songster G, Montoro M, Kjos S. Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 2000; 182: 313-320.

99. Watkins M, Botto L. Maternal prepregnancy weight and congenital heart defects in offspring. Epidemiology 2001; 12: 439-46.

100. Hendricks K, Nuno O, Suarez L, Larsen R. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology 2001; 12: 630-635.

101. Yang X, Hakan Borg L, Martin Siman C, Eriksson U. Maternal antioxidants treatments prevent diabetes-induced alterations of mitochondrial morphology in rats embryos. Anat Rec 1998; 251: 303-315.

102. Carone D, Loverro G, Greco P, Capuano F, Selvaggi L. Lipid peroxidation products and antioxidants enzymes in red blood cells during normal and diabetic pregnancy. Eur J Obstet Gynecol Reprod Biol 1993; 51: 103-109.


[page 64↓]

103. Kousseff B. Gestational diabetes mellitus (class A): a human teratogen ? Am J Med Genet 1999; 23: 402-8.

104. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev 2001; 61: 85-95.

105. Sheffield J, Butler-Koster E, Casey B, McIntire D, Leveno K. Maternal diabetes mellitus and infant malformations. Obstet Gynecol 2002; 100: 925-30.

106. Farrell T, Neale L, Cundy T. Congenital anomalies in offspring of women with type1, type 2 and gestational diabetes. Diabetic Med 2002; 19: 322-6.

107. Schäfer U, Vogel M, Unger M, Dupak J, Vetter K. Zottenreifungsstörungen der Plazenta bei geringgradigen Glucosestoffwechselstörungen. Geburtsh. u. Frauenheilk. 1997; 57: 256-262.

108. Hawdon J, Ward-Platt M, Aynsley A. Prevention and management of neonatal hypoglycemia. Arch Dis Child Fetal Neonatal 1994; 70: 60-64.

109. Cornblath M, Hawdon J, Williams A, Aynsley-Green A, Ward-Platt M, Schwarzt R, et al. Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics 2000; 105: 1141-5.

110. Schaefer-Graf U, Wilke A, Kjos S, Bührer C, Dudenhausen J, Vetter K. Predictors for neonatal hypoglycemia in large-for-gestational age newborns. Am J Obstet Gynecol 2002; 185: S197.

111. Pettitt DJ. Gestational diabetes and impaired glucose tolerance during pregnancy. Diabetes 1985; 34 (Suppl 2): 119-21.

112. No authors. The hyperglycemia and adverse pregnancy outcome study (HAPO). Int J Gynecol Obstet 2002; 78: 69-77.

113. Schaefer-Graf U, Heuer R, Kilavuz Ö, Pandura A, Henrich W, Vetter K. Maternal obesity not maternal glucose values correlates best with high rates of fetal macrosomia in pregnancies complicated by gestational diabetes. J Perinat Med 2002; 30 (4): 313-321.

114. Goldman M, Kitzmiller J, Abrams B, Cowan R, Laros R. Obstetric complications with GDM. Effects of maternal weight. Diabetes 1991; 40 (Suppl): 79-82.

115. Perlow J, Morgan M, Montgomery D, Towers C, Porto M. Perinatal outcome complicated by massive obesity. Am J Obstet Gynecol 1992; 167: 958-962.


[page 65↓]

116. Lu G, Rouse D, DuBard M, Cliver S, Kimberlin D, Hauth J. The effect of the increasing prevalence of maternal obesity on perinatal morbidity. Am J Obstet Gynecol 2001; 185: 845-9.

117. Castro L, Avina R. Maternal obesity and pregnancy outcomes. Curr Opin Obstet Gynecol 2002; 14: 601-606.

118. Marquette G, Francoeur D, Skoll M. The incidence of fetal macrosomia in hyperinsulinemic euglycemic patients. K Matern Fetal Invest 1995; 5: 33-35.

119. Merzouk H, Meghelli-Bouchenak M, Loukidi B, Prost J, Belleville J. Impaired serum lipids and lipoproteins in fetal macrosomia related to maternal obesity. Biol Neonate 2000; 77(1): 17-24.

120. Catalano P, Thomas A, Avallone D, Amini S. Anthropometric estimation of neonatal body composition. Am J Obstet Gynecol 1995; 173: 1176-81.

121. Catalano PM, Tzybir, E.D., Allan, S.R., McBean, J.H., McAuliffe, T.L. Evaluation of fetal growth by estimation of neonatal body composition. Obstet Gynecol 1992; 79: 46-50.

122. Knopp R, Magee M, Raisys V, Benedetti T. Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 1991; 40 (Suppl 2): 165-71.

123. Bjoerk O, Persson, B. Placental changes in relation to the degree of metabolic control in diabetes mellitus. Placenta 1982; 3: 367-378.

124. Diamant Y. The human placenta in diabetes mellitus. A review. Isr J Med Sci 1991; 27(8-9): 493-7.

125. Jansson T, Ekstrand Y, Bjorn C, Wennergen M, Powell T. Alterations in the activity of placental amino acid transporters in pregnancies complicated by diabetes. Diabetes 2002; 51: 2214-9.

126. Weiss P. Lessons from the fetus. In: Dornhorst A, Hadden D, eds. Diabetes and pregnancy . Wiley: Chichester; 1996: 221-40.

127. Persson B, Heding LG. Fetal beta cell function in diabetic pregnancy. Am J Obstet Gynecol 1982; 144: 455-459.

128. Schwartz L. Hyperinsulinemia and macrosomia. N Engl J Med 1990; 323(5): 340-342.

129. Schaefer-Graf U, Kjos S, Bühling K, Henrich W, Brauer M, Heinze T, et al. Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes. Diabetic Med 2003; in press.


[page 66↓]

130. McLaren R, Puckett J, Chauhan S. Estimates of birth weight in pregnant women requiring insulin: a comparison of seven sonographic models. Obstet Gynecol 1995; 85: 565-569.

131. Smith G, Smith M, McNay M, Fleming J. The relation between fetal abdominal circumference and birth weight: finding in 3512 pregnancies. Br J Obstet Gynaecol 1997; 104: 186-190.

132. Bernstein IM, Catalano PM. Influence of fetal fat on the ultrasound estimation of fetal weight in diabetic mothers . Obstet Gynecol 1992 ; 79 : 561-563 .

133. Deutsche Gesellschaft für Ernährung. Ernährungsbericht 2000. 2001.

134. Senatsverwaltung für Arbeit, Soziales und Familie. Zur gesundheitlichen Lage von Kindern in Berlin (The health status of children in Berlin). Gesundheitsberichterstattung Berlin. 2001.

135. Schaefer-Graf UM, Kjos SL, Ostary Fauzan, Buehling KJ , Siebert G Barbara Ladendorf B, Bührer C, Dudenhausen JW, Vetter K. A randomized trial evaluating a predominately fetal-growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care 27 (2004) 297-302


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML generated:
15.06.2004